LU
Lupin Limited
LUPIN.NS·NSEMumbai INFounded 196816,000 employees
Mid CappharmaPublicRespiratoryCardiology
Platform: Complex Generic
Market Cap
$8B
All Drugs
4
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (LUPIN.NS)
Loading LUPIN.NS stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelicapivasertib | LUP-9680 | Preclinical | 1 | Menin | SCLCUC | ||
| Voxanesiran | LUP-6836 | Phase 1 | 1 | CD47 | AngelmanTTR Amyloidosis | ||
| Lisosacituzumab | LUP-651 | Phase 1 | 1 | IL-23 | CSU | ||
| LUP-4095 | LUP-4095 | Phase 2/3 | 2 | Tau | Endometrial Ca |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Lupin Limited trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)